Raw Material Optimization to Bend the Biopharmaceutical Cost Curve

Raw materials sourced from sole third-party suppliers have been identified as one of the key risks to Amgen’s operation. This project aims to reduce raw material costs through sourcing alternative materials and optimizing material consumption. To systematically evaluate alternative material supp...

Full description

Bibliographic Details
Main Author: Chen, Julia Mengpei
Other Authors: Zheng, Yanchong
Format: Thesis
Published: Massachusetts Institute of Technology 2022
Online Access:https://hdl.handle.net/1721.1/139545